Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DAN2C4
|
|||
| Drug Name |
SYNB-1934
|
|||
| Indication | Phenylketonuria [ICD-11: 5C50.0; ICD-10: E70, E70.1] | Phase 3 | [1] | |
| Company |
Synlogic Cambridge, MA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05764239) A Phase 3, Double-blind, Placebo-controlled, Randomized Withdrawal Study to Evaluate the Efficacy and Safety of SYNB1934 in Patients With PKU (SYNPHENY-3). U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.